What Surgical Oncologists Need to Know About Managing Esophageal Cancer – An Innovative Whiteboard View

FACULTY


Yelena Y. Janjigian, MD
Associate Attending Physician
Associate Professor, WCMC
Chief, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY

Daniela Molena, MD
Associate Professor of Surgery
Director of Esophageal Surgery
Thoracic Surgery
Memorial Sloan Kettering Cancer Center
New York, NY

PROGRAM OVERVIEW

This case-based activity will explore the role of surgical oncologists in the management of esophageal cancer, review emerging clinical trial data on the use of immune checkpoint inhibitors as adjuvant therapy, and examine strategies to appropriately sequence therapies using patient-specific factors.


TARGET AUDIENCE

This educational activity is specifically designed for US-based surgical oncologists and other healthcare professionals involved in the treatment of patients with esophageal cancer.


LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Describe the role of surgical oncologists in esophageal cancer (EC) screening and surveillance
  • Review data from clinical trials on the efficacy and safety of immune checkpoint inhibitors (ICIs) for the treatment of patients with advanced EC across lines of therapy
  • Discuss clinical trial data on the efficacy and safety of ICIs used as adjuvant treatment for malignancies including EC

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.


CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.


CNE ACCREDITATION STATEMENT

Ultimate Medical Academy / CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission of Accreditation.


NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with Esophageal Cancer.
CNE Credits: 1.0 ANCC Contact Hour.


COMMISSION ON DIETETIC REGISTRATION

This program has received prior approval with the Commission on Dietetic Registration for dietitians and RDs.

*Dietitians may also submit feedback on the activity to qualityCPEU@eatright.org.


DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.



DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Janjigian is a consultant for BMS, Merck Serono, Rgenix, Eli Lilly, and Daiichi Sankyo. She conducts research for Rgenix, Boehringer Ingelheim, Bayer, Genentech/Roche, BMS, Eli Lilly, and Merck. Dr. Janjigian also collects royalties from Pfizer, Bayer, Imugene, Merck, Zymeworks, Basilea Pharamceutica, AstraZeneca and owns stock in Rgenix.

Dr. Molena is a consultant for Intuitive, Johnson & Johnson, Boston Scientific, Urogen, and AstraZeneca.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

Staff, Planners, and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Diana Tommasi, PharmD, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Morgan Kravarik, Program Coordinator for Med Learning Group, has nothing to disclose.


DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.


METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the activity.
  3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.


DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

RELEASE DATE: April 2, 2021

EXPIRATION DATE: April 2, 2022

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com.

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.